ATE368048T1 - Partielle und volle agonisten von a1- adenosinrezeptoren - Google Patents

Partielle und volle agonisten von a1- adenosinrezeptoren

Info

Publication number
ATE368048T1
ATE368048T1 AT03788541T AT03788541T ATE368048T1 AT E368048 T1 ATE368048 T1 AT E368048T1 AT 03788541 T AT03788541 T AT 03788541T AT 03788541 T AT03788541 T AT 03788541T AT E368048 T1 ATE368048 T1 AT E368048T1
Authority
AT
Austria
Prior art keywords
sup
optionally substituted
cycloalkyl
hydrogen
partial
Prior art date
Application number
AT03788541T
Other languages
English (en)
Inventor
Jeff Zablocki
Venkata Palle
Elfatih Elzein
Xiaofen Li
Original Assignee
Cv Therapeutics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cv Therapeutics Inc filed Critical Cv Therapeutics Inc
Application granted granted Critical
Publication of ATE368048T1 publication Critical patent/ATE368048T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/16—Purine radicals
    • C07H19/167—Purine radicals with ribosyl as the saccharide radical
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/16—Purine radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Diabetes (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Cardiology (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Immunology (AREA)
  • Emergency Medicine (AREA)
  • Child & Adolescent Psychology (AREA)
  • Pain & Pain Management (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Transplantation (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Endocrinology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
AT03788541T 2002-08-15 2003-08-15 Partielle und volle agonisten von a1- adenosinrezeptoren ATE368048T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US40371202P 2002-08-15 2002-08-15
US45009403P 2003-02-25 2003-02-25

Publications (1)

Publication Number Publication Date
ATE368048T1 true ATE368048T1 (de) 2007-08-15

Family

ID=31891396

Family Applications (1)

Application Number Title Priority Date Filing Date
AT03788541T ATE368048T1 (de) 2002-08-15 2003-08-15 Partielle und volle agonisten von a1- adenosinrezeptoren

Country Status (15)

Country Link
US (2) US7022681B2 (de)
EP (1) EP1537133B1 (de)
JP (1) JP4596913B2 (de)
KR (1) KR20050067384A (de)
CN (1) CN100480255C (de)
AT (1) ATE368048T1 (de)
AU (1) AU2003263846B2 (de)
CA (1) CA2495370A1 (de)
DE (1) DE60315164T2 (de)
ES (1) ES2288632T3 (de)
MX (1) MXPA05001844A (de)
NO (1) NO20051296L (de)
NZ (1) NZ538590A (de)
RU (1) RU2340623C2 (de)
WO (1) WO2004016635A2 (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1636229A4 (de) 2003-06-06 2008-07-30 Endacea Inc A1-adenosinrezeptorantagonisten
EP2158208B1 (de) * 2007-05-17 2015-04-08 Gilead Sciences, Inc. Verfahren zur herstellung eines a2a-adenosinrezeptoragonisten sowie dessen polymorphe
JP2014530910A (ja) * 2011-10-24 2014-11-20 グラクソスミスクライン、インテレクチュアル、プロパティー、ナンバー２、リミテッドＧｌａｘｏｓｍｉｔｈｋｌｉｎｅ Ｉｎｔｅｌｌｅｃｔｕａｌ Ｐｒｏｐｅｒｔｙ Ｎｏ．２ Ｌｉｍｉｔｅｄ 新規化合物
WO2016135582A1 (en) * 2015-02-24 2016-09-01 Pfizer Inc. Substituted nucleoside derivatives useful as anticancer agents

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1254888A (en) * 1984-10-26 1989-05-30 Bharat Trivedi N.sup.6-bicycloadenosines
US5140015A (en) * 1990-02-20 1992-08-18 Whitby Research, Inc. 2-aralkoxy and 2-alkoxy adenosine derivatives as coronary vasodilators and antihypertensive agents
USRE36494E (en) * 1990-02-20 2000-01-11 Discovery Therapeutics, Inc. 2-aralkoxy and 2-alkoxy adenosine derivatives as coronary vasodilators and antihypertensive agents
US5278150A (en) * 1992-04-24 1994-01-11 Whitby Research, Inc. 2-hydrazoadenosines and their utility for the treatmeat of vascular conditions
US5589467A (en) * 1993-09-17 1996-12-31 Novo Nordisk A/S 2,5',N6-trisubstituted adenosine derivatives
AU2022597A (en) * 1996-03-13 1997-10-01 Novo Nordisk A/S A method of treating disorders related to cytokines in mammals
WO1998016539A1 (en) * 1996-10-14 1998-04-23 Novo Nordisk A/S Novel therapeutically active adenosine derivatives
GB9723589D0 (en) * 1997-11-08 1998-01-07 Glaxo Group Ltd Chemical compounds
GB9813554D0 (en) * 1998-06-23 1998-08-19 Glaxo Group Ltd Chemical compounds
US20040162422A1 (en) * 2001-03-20 2004-08-19 Adrian Hall Chemical compounds

Also Published As

Publication number Publication date
JP4596913B2 (ja) 2010-12-15
KR20050067384A (ko) 2005-07-01
US20060135467A1 (en) 2006-06-22
CA2495370A1 (en) 2004-02-26
RU2005106997A (ru) 2005-11-10
WO2004016635A2 (en) 2004-02-26
MXPA05001844A (es) 2005-04-19
NZ538590A (en) 2006-10-27
AU2003263846A1 (en) 2004-03-03
US7022681B2 (en) 2006-04-04
AU2003263846B2 (en) 2009-12-17
JP2006505525A (ja) 2006-02-16
RU2340623C2 (ru) 2008-12-10
NO20051296L (no) 2005-05-13
CN1675235A (zh) 2005-09-28
EP1537133A2 (de) 2005-06-08
US20040043960A1 (en) 2004-03-04
CN100480255C (zh) 2009-04-22
ES2288632T3 (es) 2008-01-16
WO2004016635A3 (en) 2004-04-08
DE60315164T2 (de) 2008-04-30
EP1537133B1 (de) 2007-07-25
DE60315164D1 (de) 2007-09-06

Similar Documents

Publication Publication Date Title
DK1401837T3 (da) Purinderivater som A2B-adenosinreceptorantagonister
TW200716639A (en) Fused heterocyclic compounds
NO20055333L (no) Indazolderivater
ATE239710T1 (de) Benzoheterocyclische derivate verwendbar als vasopressin- oder oxytocin-modulatoren
CY1107221T1 (el) Παραγωγα τριαζολιου ως ανταγωνιστες υποδοχεα ταχυκινινης
PE20061297A1 (es) Compuestos derivados de cromano y cromeno moduladores del receptor de serotonina 5-ht2c
CO6280442A2 (es) Derivados espiroheterocíclicos de pirrolidindiona útiles como pesticidas
ES2175615T3 (es) Derivados de azaindol etilamina como agentes de union al receptor nicotinico de acetilcolina.
ATE319706T1 (de) Pyridinon und pyridinethion-derivate mit hiv- hemmenden eigenschaften
ATE409177T1 (de) Synthetische multiple quaternäre ammoniumsalze
NO20051296L (no) Partielle og fullstendige agonister av A1-adenosinreseptorer
DE69813605D1 (de) Benzofuranderivate
EA200501049A1 (ru) Замещенные бензоилпроизводные в качестве гербицидов
TW200628446A (en) Substituted pyrrole derivative
TW200510320A (en) Aminoquinoline derivatives and their use as adenosine A3 ligands
EA200301317A1 (ru) Производные аминохинолина и его применение в качестве лигандов аденозина a3
ES2197003A1 (es) Nuevos compuestos antagonistas de integrinas alfa.
WO2005061475A3 (en) Ornithine derivatives as prostaglandin e2 agonists or antagonists
DE60016384D1 (de) Chondrogonese promotoren und indolin-2-on derivate
ATE355291T1 (de) A2a adenosinrezeptorantagonisten
PT1261588E (pt) Compostos imidazole como antagonistas dos adrenoceptores
DE69319900D1 (de) N,n'-disubstituierte amidderivate
NO20002833L (no) Alisykliske, acylerte heterosykliske derivater
DE60100811D1 (de) Crf rezeptor-antagonisten und darauf bezogene methoden
AR017057A1 (es) Derivados de pirimidinona y herbicidas que los contienen

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties